Ann: First patient dosed in Phase 1 bile tract cancer trial, page-56

IMO, second patient to be dosed with VAXINIA in the MAST bile tract cancer expansion cohort will be at the City of Hope site under the watchful eye of Yuman Fong and his fellow researchers. The current delay could be the holiday season currently in the US. Maybe the bile tract cancer patient recently dosed in the OASIS trial at the City of Hope was prioritized.

Looking forward to many more ASX company announcements between now and the AGM,

Imugene's website holds a wealth of information and research,necessary for shareholders to make their own informed opinion for their investment decisions.

Regards.